151 reports of this reaction
1.4% of all BRIVARACETAM reports
#14 most reported adverse reaction
EPILEPSY is the #14 most commonly reported adverse reaction for BRIVARACETAM, manufactured by Apotex Corp.. There are 151 FDA adverse event reports linking BRIVARACETAM to EPILEPSY. This represents approximately 1.4% of all 10,449 adverse event reports for this drug.
Patients taking BRIVARACETAM who experience epilepsy should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EPILEPSY is a less commonly reported adverse event for BRIVARACETAM, but still significant enough to appear in the safety profile.
In addition to epilepsy, the following adverse reactions have been reported for BRIVARACETAM:
The following drugs have also been linked to epilepsy in FDA adverse event reports:
EPILEPSY has been reported as an adverse event in 151 FDA reports for BRIVARACETAM. This does not prove causation, but indicates an association observed in post-market surveillance data.
EPILEPSY accounts for approximately 1.4% of all adverse event reports for BRIVARACETAM, making it a notable side effect.
If you experience epilepsy while taking BRIVARACETAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.